Skip to content

Products and materials referenced on PeptideRank are for research use only and educational use, and are not for human consumption. Nothing on this site is medical advice. PeptideRank may earn an affiliate commission from some outbound links. Discount codes give a discount. Payment does not drive the evidence ranking.

PeptideRank

NextGen Peps vs Healius Peptides: COA & Testing Comparison (2026)

NextGen Peps and Healius Peptides are both grade A on the published rubric. NextGen Peps is rank 2 and Healius Peptides is rank 4. That order is the published tie-break inside the grade. It is not a guarantee of quality, purity, safety, or outcomes.

NextGen Peps vs Healius Peptides: COA & Testing Comparison (2026)
Public recordNextGen PepsHealius Peptides
GradeGrade AGrade A
SignalSupplier-stated. COA library with about 65 dated rows across Bioregen, Bioviridian and Janoshik, Jul 2025 to Sep 25 2026, some with endotoxin (Supplier-stated)Supplier-stated. Lot-specific HPLC table on the product page (lots HP9520821385-5/-10, Feb 2 2026, 99.89%); Janoshik named (Supplier-stated)
LimitationFinnrick profile shows 0 tests, so no independent coverageNo independent dataset found; the newest dated lot captured is Feb 2026
COA availabilitySupplier-stated. A public COA library lists batch documents and can be filtered by laboratory. The BPC-157 product page includes a control labeled View COA for the 5 mg vial. SourceSupplier-stated. The BPC-157 product page publishes lot-specific HPLC results, including lot HP9520821385-5 for the 5 mg vial and lot HP9520821385-10 for the 10 mg vial, both dated February 2, 2026. Source
Named labSupplier-stated. The public COA library names Janoshik on listed certificates. SourceSupplier-stated. The affiliate program page says every peptide vial has an accessible third-party lab test from Janoshik. Source
CodeCONTINUE (10% off)mario10 (10% off)

The ranking is not a quality guarantee. One strong certificate of analysis does not validate the whole catalog. Verify each batch.

Back to the 2026 evidence ranking